Hoover, AL, United States of America

Jeonga Kim

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2020.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeonga Kim: Innovator in Rexinoid Compounds

Introduction

Jeonga Kim is a notable inventor based in Hoover, Alabama, recognized for his contributions to the field of metabolic disorders and cancer treatment. His innovative work focuses on the development of novel rexinoid compounds, which have significant implications for medical science.

Latest Patents

Jeonga Kim holds a patent for "Rexinoid compounds and methods of using rexinoid compounds for treating metabolic disorders and cancer." This patent outlines the creation of new rexinoid compounds and describes methods for utilizing these compounds to address various health issues, including metabolic disorders, diabetes, insulin resistance, glucose intolerance, obesity, steatosis, inflammation, and cancer. He has 1 patent to his name, showcasing his commitment to advancing medical research.

Career Highlights

Kim is affiliated with the UAB Research Foundation, where he continues to explore innovative solutions in the realm of health and medicine. His work is characterized by a strong focus on the intersection of chemistry and biology, aiming to develop effective treatments for complex diseases.

Collaborations

Throughout his career, Jeonga Kim has collaborated with esteemed colleagues, including Donald D. Muccio and Venkatram Reddy Atigadda. These partnerships have enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Jeonga Kim's work in developing rexinoid compounds represents a significant advancement in the treatment of metabolic disorders and cancer. His dedication to research and innovation continues to inspire progress in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…